Company News
Jenburkt Pharmaceuticals Board Meeting May 5
Jenburkt Pharmaceuticals schedules board meeting on May 5, 2026, to review FY26 and Q4 results.
Board will consider recommending dividend for shareholders during the scheduled meeting.
Disclosure made